Cite
HARVARD Citation
Slatinska, J. et al. (n.d.). Do C1q-Positive Donor Specific Antibodies have Prognostic Effect in Patients with Resistant Antibody-Mediated Rejection Treated with Bortezomib? Single-Centre Experience. Transplantation. p. . [Online].